1989 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Our principal scientific interest is in cells of the innate immune system and their contribution to the pathogenesis and treatment of disease, specifically related to cancer and immunotherapy. In the past years our group has focused on the role of phagocytes, such as macrophages and neutrophilic granulocytes, during monoclonal antibody therapy in cancer. We have, amongst other things, been exploring the basic mechanisms by which innate immune cells destroy antibody-opsonized cancer cells, which has most recently led us to identify the cytotoxic effector mechanism employed by neutrophils in this context (Matlung et al. (2018) Cell Reports 23:3946). Furthermore, we have been trying to identify the relevant immune checkpoints that control antibody-dependent cellular cytotoxicity (ADCC) by innate immune cells. As such we have found that interactions between CD47 expressed on cancer cells and SIRPα expressed on phagocytes, including neutrophils and macrophages, plays a very important role in limiting ADCC exerted by these cells (Zhao et al. (2011) PNAS 108:18342; Barclay and van den Berg (2014) Annu Rev Immunol. 32:25; Matlung et al. (2017)Immunol Rev. 276:145) . We are currently, in collaboration with Synthon Biopharmaceuticals, developing antagonists of the CD47-SIRPα interaction that we aim to combine with a variety of available cancer antibody therapeutics.

 

Together with the pediatric immunologists prof. dr. Taco W. Kuijpers our joined research group has also been active in the diagnosis and identification of rare primary immunodeficiency (PID) syndromes As such we have identified a number of novel primary immunodeficiency syndromes in our laboratory, including e.g. Leukocyte adhesion deficiency syndrome type 3 (LAD3) (Kuijpers et al. (2009) Blood. 113:4740) and ARPC1B-deficiency (Kuijpers et al. (2017) J Allergy Clin Immunol. 140:273).

 

Finally, we have been exploring the interactions of innate immune cells and red blood cells and platelets in other blood cell disorders, specifically in the context of blood transfusion research. As such we have been investigating genetic risk determinants of alloimmunization of transfused Sickle cell disease patients (Meinderts et al (2017) Blood 130:2121).

Education/Academic qualification

PhD

1 Sep 198831 Dec 1992

Master

1 Sep 198231 Aug 1988

External positions

Head Department of Blood Cell Research, Sanquin Research

1 Jun 2009 → …

Head Phagocyte Laboratory, Sanquin Research

1 Feb 2007 → …

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A comprehensive proteomics study on platelet concentrates: Platelet proteome, storage time and Mirasol pathogen reduction technology

Salunkhe, V., De Cuyper, I. M., Papadopoulos, P., van der Meer, P. F., Daal, B. B., Villa-Fajardo, M., de Korte, D., van den Berg, T. K. & Gutiérrez, L., 3 Apr 2019, In : Platelets. 30, 3, p. 368-379 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair

Aarts, C. E. M., Hiemstra, I. H., Béguin, E. P., Hoogendijk, A. J., Bouchmal, S., van Houdt, M., Tool, A. T. J., Mul, E., Jansen, M. H., Janssen, H., van Alphen, F. P. J., de Boer, J-P., Zuur, C. L., Meijer, A. B., van den Berg, T. K. & Kuijpers, T. W., 26 Nov 2019, In : BLOOD ADVANCES. 3, 22, p. 3562-3574 13 p.

Research output: Contribution to journalArticleAcademicpeer-review

Extensive Ethnic Variation and Linkage Disequilibrium at the FCGR2/3 Locus: Different Genetic Associations Revealed in Kawasaki Disease

Nagelkerke, S. Q., Tacke, C. E., Breunis, W. B., Tanck, M. W. T., Geissler, J., Png, E., Hoang, L. T., van der Heijden, J., Naim, A. N. M., Yeung, R. S. M., Levin, M. L., Wright, V. J., Burgner, D. P., Ponsonby, A-L., Ellis, J. A., Cimaz, R., Shimizu, C., Burns, J. C., Fijnvandraat, K., van der Schoot, C. E. & 8 others, van den Berg, T. K., de Boer, M., Davila, S., Hibberd, M. L., Kuijpers, T. W., Dahdah, N., Kone-Paut, I. & International Kawasaki Disease Genetics Consortium, 1 Jan 2019, In : Frontiers in Immunology. 10, MAR, p. 185 185.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

FcγRIIIb restricts antibody-dependent destruction of cancer cells by human neutrophils

Treffers, L. W., van Houdt, M., Bruggeman, C. W., Heineke, M. H., Zhao, X. W., van der Heijden, J., Nagelkerke, S. Q., Verkuijlen, P. J. J. H., Geissler, J., Lissenberg-Thunnissen, S., Valerius, T., Peipp, M., Franke, K., van Bruggen, R., Kuijpers, T. W., van Egmond, M., Vidarsson, G., Matlung, H. L. & van den Berg, T. K., 1 Jan 2019, In : Frontiers in Immunology. 10, JAN, 03124.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy

Logtenberg, M. E. W., Jansen, J. H. M., Raaben, M., Toebes, M., Franke, K., Brandsma, A. M., Matlung, H. L., Fauster, A., Gomez-Eerland, R., Bakker, N. A. M., van der Schot, S., Marijt, K. A., Verdoes, M., Haanen, J. B. A. G., van den Berg, J. H., Neefjes, J., van den Berg, T. K., Brummelkamp, T. R., Leusen, J. H. W., Scheeren, F. A. & 1 others, Schumacher, T. N., 1 Apr 2019, In : Nature Medicine. 25, 4, p. 612-619 8 p.

Research output: Contribution to journalLetterAcademicpeer-review